Sugi Holdings CoSGIPF 97 Return-on-Tangible-Equity is 15.95% as of Feb. 2026, which is 46% above its 10-year median of 10.95. GuruFocus rates SGIPF with a GF Score™ of 97/100 and a GF Value™ of $17.63. The stock has 4 warning signs investors should review. Among 579 Healthcare Providers & Services companies, Sugi Holdings Co ranks better than 67.88% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Sugi Holdings Co's annualized net income for the quarter that ended in Feb. 2026 was $240 Mil. Sugi Holdings Co's average shareholder tangible equity for the quarter that ended in Feb. 2026 was $1,506 Mil. Therefore, Sugi Holdings Co's annualized Return-on-Tangible-Equity for the quarter that ended in Feb. 2026 was 15.95%.
The historical rank and industry rank for Sugi Holdings Co's Return-on-Tangible-Equity or its related term are showing as below:
SGIPF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.14 Med: 10.95 Max: 20.56
Current: 20.35
During the past 13 years, Sugi Holdings Co's highest Return-on-Tangible-Equity was 20.56%. The lowest was 9.14%. And the median was 10.95%.
SGIPF's Return-on-Tangible-Equity is ranked better than 67.88% of 579
companies
in the Healthcare Providers & Services industry
Industry Median: 10.13
vs SGIPF: 20.35
Sugi Holdings Co (OTCPK:SGIPF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Sugi Holdings Co Return-on-Tangible-Equity Related Terms
Sugi Holdings Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Sugi Holdings Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sugi Holdings Co Return-on-Tangible-Equity Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sugi Holdings Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sugi Holdings Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sugi Holdings Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Sugi Holdings Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Feb. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 15.95% mean?
Sugi Holdings Co (SGIPF) has a Return-on-Tangible-Equity of 15.95% as of Feb. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sugi Holdings Co and its competitors. This is 46% above median its historical median of 10.95. Over the past decade, Sugi Holdings Co's Return-on-Tangible-Equity has ranged from 9.14 to 20.56. According to the industry distribution chart, Sugi Holdings Co ranks #186 out of 579 companies in the Healthcare Providers & Services industry, placing it in the top 32.1%.
Is Sugi Holdings Co's Return-on-Tangible-Equity too high?
Sugi Holdings Co's current Return-on-Tangible-Equity of 15.95% is 46% above median its 10-year median of 10.95. Over the past 10 years, this metric has ranged from a low of 9.14 to a high of 20.56. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.13. Sugi Holdings Co's value of 15.95% is 57.5% above this industry median. Based on the distribution chart, Sugi Holdings Co ranks #186 out of 579 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sugi Holdings Co has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Sugi Holdings Co's Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sugi Holdings Co ranks #186 out of 579 companies for Return-on-Tangible-Equity. This puts Sugi Holdings Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.13. Sugi Holdings Co's value of 15.95% is 57.5% above this benchmark. Historically, Sugi Holdings Co's own Return-on-Tangible-Equity has ranged from 9.14 to 20.56 over the past decade. While the company's 10-year median is 10.95 vs. the industry median of 10.13, Sugi Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.13, based on 579 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sugi Holdings Co's current Return-on-Tangible-Equity of 15.95% is 57.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sugi Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sugi Holdings Co's current Return-on-Tangible-Equity is 15.95%, which is 46% above median its own 10-year median of 10.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sugi Holdings Co stock overvalued right now?
Sugi Holdings Co (SGIPF) has a current Return-on-Tangible-Equity of 15.95%. The stock's GF Value™ is $17.63, compared to a current price of $16.29 — trading 7.6% below its estimated fair value. The current Return-on-Tangible-Equity is 15.95%, which is 46% above median its 10-year median of 10.95 and 57.5% above the Healthcare Providers & Services industry median of 10.13. Sugi Holdings Co's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Sugi Holdings Co (SGIPF), the current Return-on-Tangible-Equity is 15.95% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sugi Holdings Co (SGIPF) Overvalued in 2026?
Based on GuruFocus' analysis, Sugi Holdings Co stock appears to be undervalued.
The current stock price of $16.29 is trading 7.6% below its estimated GF Value™ of $17.63.
Key valuation signals for SGIPF:
Return-on-Tangible-Equity: 15.95% (46% above median its 10-year median of 10.95)
GF Value™: $17.63 vs. price of $16.29 (7.6% below fair value)
Industry Position: 57.5% above the Healthcare Providers & Services median (#186 of 579)
No single metric tells the full story. See the SGIPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sugi Holdings Co Ltd is a Japan-based company engaged in drugstore operations and the pharmaceutical dispensing business. Through its subsidiaries, the company is involved in selling pharmaceuticals, health foods, cosmetics, daily essentials, and prescription drugs. It also operates community-based drugstores that support home healthcare in collaboration with local medical professionals. The company also supports regional healthcare facilities and provides at-home nursing services.
97GF Score
Get the complete analysis for SGIPF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGIPF has been successfully added to your 
